A detailed history of American Century Companies Inc transactions in A Tyr Pharma Inc stock. As of the latest transaction made, American Century Companies Inc holds 61,596 shares of LIFE stock, worth $114,568. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61,596
Previous 60,487 1.83%
Holding current value
$114,568
Previous $94,000 21.28%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.51 - $2.24 $1,674 - $2,484
1,109 Added 1.83%
61,596 $114,000
Q2 2024

Aug 07, 2024

BUY
$0.0 - $2.07 $0 - $13,339
6,444 Added 11.92%
60,487 $94,000
Q1 2024

May 14, 2024

BUY
$1.42 - $2.02 $45,387 - $64,565
31,963 Added 144.76%
54,043 $105,000
Q4 2023

Feb 13, 2024

BUY
$1.11 - $1.51 $24,508 - $33,340
22,080 New
22,080 $31,000
Q3 2023

Nov 13, 2023

BUY
$1.55 - $2.23 $12,227 - $17,592
7,889 Added 55.59%
22,080 $34,000
Q2 2023

Aug 14, 2023

BUY
$1.72 - $2.57 $24,408 - $36,470
14,191 New
14,191 $30,000

Others Institutions Holding LIFE

About aTYR PHARMA INC


  • Ticker LIFE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,625,000
  • Market Cap $53.2M
  • Description
  • aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...
More about LIFE
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.